Patheon Can't Duck JV Partner's Suit Over $255M Acquisition

Law360, New York (February 25, 2013, 8:04 PM EST) -- A Florida federal judge said Friday that Procaps SA can contest joint venture partner Patheon Inc.'s $255 million acquisition of a pharmaceutical company, shooting down Patheon's argument that Procaps actually stood to benefit from the deal's alleged anti-competitive impacts.

U.S. District Judge Donald L. Graham ruled that Procaps — which previously agreed to collaborate with Patheon on development of a softgel capsule service for pharmaceutical products — had standing to bring its complaint under antitrust laws, according to an order. Procaps alleged in the suit that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.